Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBPP) Times Interest Earned (2016 - 2025)

Regen BioPharma (RGBPP) has disclosed Times Interest Earned for 12 consecutive years, with -$1.43 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 66.37% to -$1.43 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.14, a 62.86% increase, with the full-year FY2025 number at -$2.14, up 62.86% from a year prior.
  • Times Interest Earned was -$1.43 for Q3 2025 at Regen BioPharma, up from -$1.65 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.07 in Q3 2021 to a low of -$574.2 in Q2 2021.
  • A 5-year average of -$44.08 and a median of -$4.26 in 2024 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: crashed 74907.39% in 2021, then surged 99.66% in 2022.
  • Regen BioPharma's Times Interest Earned stood at -$3.04 in 2021, then crashed by 779.08% to -$26.72 in 2022, then surged by 74.16% to -$6.9 in 2023, then skyrocketed by 64.93% to -$2.42 in 2024, then soared by 40.88% to -$1.43 in 2025.
  • Per Business Quant, the three most recent readings for RGBPP's Times Interest Earned are -$1.43 (Q3 2025), -$1.65 (Q2 2025), and -$5.08 (Q1 2025).